21 channels in a network of protein-interactions is a crucial requirement for proper regulation of channel activity. In this study, we took advantage of the specific properties of the yeast split-ubiquitin system to search for and characterize so far unknown interaction partners of Ca V 2 Ca 21 channels. We identified tetraspanin-13 (TSPAN-13) as an interaction partner of the a 1 subunit of N-type Ca V 2.2, but not of P/Q-type Ca V 2.1 or L-and T-type Ca 21 channels. Interaction could be located between domain IV of Ca V 2.2 and transmembrane segments S1 and S2 of TSPAN-13. Electrophysiological analysis revealed that TSPAN-13 specifically modulates the efficiency of coupling between voltage sensor activation and pore opening of the channel and accelerates the voltage-dependent activation and inactivation of the . Even though these and other studies shed light on the complex protein networks involved in the subtype-specific modulation of Ca V 2 family members, many aspects underlying their regulation remain unknown and could probably be accredited to yet unidentified interaction partners. Different methodical approaches aiming at the identification of Ca 21 channel interaction partners might favour certain protein-protein interactions based on their biochemical character. Therefore the use of alternative methods to characterize the interactome of Ca 21 channels is desirable. Screening of cDNA libraries using specific bait proteins in yeast two-hybrid (YTH) assays has revealed so far unknown protein-protein interactions, which often are essential for complex regulatory mechanisms 4 . The use of Ca V 2.1 and Ca V 2.2 domains as bait proteins in a classical YTH system identified active zone RIM proteins as being presynaptic Ca 21 channel tethering adapter molecules that facilitate fast and synchronous neurotransmitter release 5 . However, due to intrinsic limitations of the classical YTH system, interactions between hydrophobic membrane proteins are not detected. A modified YTH system makes use of a split-ubiquitin which reconstitutes upon interaction of fused bait and prey proteins allowing for the detection of protein-protein interactions within or close to plasma membranes 6 . This experimental setup enables the identification and characterization of so far unknown interaction partners of Ca V 2 family members, which might comprise membrane proteins important for modulation of individual Ca V 2 functions.
I
n the nervous system, presynaptic Ca 21 channels of the Ca V 2 family including Ca V 2.1 and Ca V 2.2 play pivotal roles in the Ca 21 -dependent neurotransmitter release 1 . Their activity is tightly regulated by a multitude of adjacent proteins forming defined interaction platforms. Innovative and comprehensive experimental approaches like the use of affinity purification and quantitative mass spectrometry have systematically characterized Ca V 2 Ca 21 channel nanodomains 2, 3 . Even though these and other studies shed light on the complex protein networks involved in the subtype-specific modulation of Ca V 2 family members, many aspects underlying their regulation remain unknown and could probably be accredited to yet unidentified interaction partners. Different methodical approaches aiming at the identification of Ca 21 channel interaction partners might favour certain protein-protein interactions based on their biochemical character. Therefore the use of alternative methods to characterize the interactome of Ca 21 channels is desirable. Screening of cDNA libraries using specific bait proteins in yeast two-hybrid (YTH) assays has revealed so far unknown protein-protein interactions, which often are essential for complex regulatory mechanisms 4 . The use of Ca V 2.1 and Ca V 2.2 domains as bait proteins in a classical YTH system identified active zone RIM proteins as being presynaptic Ca 21 channel tethering adapter molecules that facilitate fast and synchronous neurotransmitter release 5 . However, due to intrinsic limitations of the classical YTH system, interactions between hydrophobic membrane proteins are not detected. A modified YTH system makes use of a split-ubiquitin which reconstitutes upon interaction of fused bait and prey proteins allowing for the detection of protein-protein interactions within or close to plasma membranes 6 . This experimental setup enables the identification and characterization of so far unknown interaction partners of Ca V 2 family members, which might comprise membrane proteins important for modulation of individual Ca V 2 functions.
Results Ca V 2.2 a 1 subunit interacts with tetraspanin-13. In order to identify and characterize novel interaction partners of presynaptic Ca 21 channels, we constructed bait vectors encoding Ca V 2.1 and Ca V 2.2 Ca 21 channel a 1 subunit cDNA-fragments. Since our attempts to express full-length a 1 subunit cDNA in yeast cells failed, we constructed bait-vectors encoding single domains and C-terminal fragments. We hypothesized that putative novel interaction partners might bind to the rather long intracellular C-terminus of Ca V 2 channels and selected domain IV as a kind of ''membrane anchor'' fused to the C-terminus. This construct also takes into account that putative interaction partners might bind not only to the C-terminus, but also to parts of the smaller intracellular loops within domain IV or even its transmembrane segments.
Amongst several candidate proteins TSPAN-13, a member of the tetraspanin family of membrane proteins demonstrated robust interaction with domain IV of the Ca V 2.2 a 1 subunit. The usage of a series of truncated forms identified the entire domain IV of the Ca V 2.2 a 1 subunit to be critical for the interaction with TSPAN-13 (Fig. S1a online). Interaction was confirmed by co-immunoprecipitation of Ca V 2.2-EGFP with TSPAN-13-Myc expressed in CHO cells (Fig. 1) .
Tetraspanins, as implicated by its names, consist of four transmembrane segments and are characterized by a long extracellular loop (LEL) containing a conserved CCG motif 7 . Using a yeast pelletb-galactosidase assay 7 we analysed the interaction between different TSPAN-13 deletion mutants with domain IV of the Ca V 2.2 a 1 subunit. Remarkably, the interaction between TSPAN-13 and Ca V 2.2 was not affected by deletion of transmembrane segment S3 and S4, the LEL and the C-terminus of TSPAN-13 in the mutant TSPAN-13 D(S3-Ct) (Fig. S1b online) . Interaction between TSPAN-13 D(S3-Ct) and domain IV of Ca V 2.2 was confirmed by a yeast bgalactosidase filter-lift assay. Expression of TSPAN-13 in the murine brain was demonstrated by an RT-PCR analysis (Fig. S2 online) . We identified TSPAN-13 mRNA at about equal levels in the hippocampus, neocortex and cerebellum.
TSPAN-13 affects Ca
21 -currents in NG108-15 cells. Since Ca V channel activity depends on the integrity of complex protein networks, which contain a multitude of Ca V channel interaction partners, we analysed whether TSPAN-13 affects channel properties of its putative interaction partner Ca V 2.2 using differentiated NG108-15 cells. Upon cultivation in the presence of cAMP, these cells express representatives of high-voltage-activated L-type and non-L-type (predominantly N-type) and low-voltage-activated T-type Ca 21 channels [8] [9] [10] . We compared whole-cell currents measured from differentiated NG108-15 cells transfected either with a control EGFP-vector or with a vector encoding TSPAN-13-EGFP. Amplitudes of low-voltage-activated Ca 21 currents activated by depolarization up to 220 mV were not affected by TSPAN-13 ( Fig. 2a and b) . In contrast, high-voltage-activated Ba 21 current amplitude activated by depolarization to 0 mV and above was significantly decreased (unpaired two-tail t-test; 0 mV: p 5 0.0167; 110 mV: p 5 0.0270; 120 mV: p 5 0.0177; 130 mV: p 5 0.0177). High-voltage activated Ca 21 channels were pharmacologically classified. P/Q type (Ca V 2.1) channels are absent in NG108-15 cells, since in agreement with observations by Liu and colleagues 9 , we have seen no effect of 500 nM v-agatoxin on whole-cell Ba 21 current. The specific N-type channel blocker v-conotoxin GVIA blocked 33 6 12% (mean 6 SD; n 5 10) of total current amplitude. The remaining current can be ascribed to L-type Ca 21 channels. As the variability of the proportion of channel subtypes in individual cells was high, we turned to recombinant systems. current was accompanied by a shift of the I-V relationship. In contrast to CHO cells, NG108-15 cells do express a considerable outwards K 1 current. This current was probably responsible for an apparent shift of the reversal potential which was observed in NG108-15 cells (Fig. 2b) , but was much less pronounced in CHO cells (Figure 2e ).
This result points out that TSPAN-13 might have a specific functional impact on Ca V 2.2 Ca 21 channels. TSPAN-13 suppressed the amplitude of current through Ca V 2.2 channels in NG108-15 cells and also in a cell line expressing Ca V 2.2 ( Fig. 2e) , though, the latter was statistically not significant. We optimized the voltage protocols for the analysis of possible effects of TSPAN-13 on current kinetics (Fig. 3) . TSPAN-13 significantly accelerated the kinetics of Ba 21 current activation (Fig. 3a) when time constants at individual depolarisations were compared. This acceleration was due to a shift of the voltage dependence of the activation time constant towards less depolarized membrane potentials (Table S1 online). Further, TSPAN-13 significantly accelerated the inactivation of Ba 21 current due to an enhanced proportion of the current inactivating with a fast time constant (Fig. 3b and Table 1 ). To visualise this effect we constructed model time courses of fast and slow components of both currents (Fig. 3b) (Fig. 3c versus 3a) . Co-expression of TSPAN-13 enhanced the activation time constants at individual depolarisations (Fig. 3c ), but this effect was not significant. Nevertheless, TSPAN-13 significantly decreased the steepness of the voltage dependence of Ca 21 current activation (Table S1 online). Inactivation of Ca 21 current through the Ca V 2.2 channel was not significantly altered by TSPAN-13 (Fig. 3d ).
An accelerated voltage-dependent inactivation suggests that TSPAN-13 may affect the cumulative inactivation during action potential bursts. Indeed, the total inactivation at the end of a series of action-potential-like waveforms or at the end of a high-frequency series of short depolarising pulses was enhanced by TSPAN-13, nevertheless, this effect was not significant (Fig. S3a, b, c online) . Similarly, the facilitation of recovery from voltage-dependent inactivation by TSPAN-13 was not statistically significant ( Fig. S3d and Table S2 online).
Further, we sought for effects of TSPAN-13 on gating currents, which reflect the activation process of the voltage sensor. TSPAN-13 affects gating currents of Ca V 2.2 channels. We measured gating currents of Ca V 2.2 channels by depolarizing each cell to its reversal potential (Fig. 4a) . The maximal charge Q max evaluates as an area below the gating current trace and is indicative for the number of channels expressed in the cell membrane. This value was not affected by co-expression of TSPAN-13. In addition, the kinetics of the charge movement was not changed. The time constants of the decay of the gating current traces were 0.54 6 0.02 ms (n 5 12) and 0.58 6 0.02 ms (n 5 12) for control and TSPAN-13-transfected cells, respectively.
Next, we compared the relationship between the maximal conductance G max and the maximal charge Q max for each cell (Fig. 4b) . This term reflects the efficiency of the coupling between the voltage sensor activation and the pore opening 11 . We found that the G max /Q max (Table S1 online).
As for full-length TSPAN-13, we used the G max /Q max relationship as an indicator for a functional modulation of Ca V 2.2 by various TSPAN-13 constructs (Fig. 4c ). Since the deleted segments S3 and S4 could be crucial for the functional modulation of Ca V 2.2 by TSPAN-13, we analysed whether the G max /Q max relationship is still affected by expression of TSPAN-13 D(S3-Ct) . In the presence of TSPAN-13 D(S3-Ct) , G max /Q max was significantly decreased from 0.18 6 0.01 nS/fC to 0.14 6 0.01 nS/fC (unpaired two-tail t-test p 5 0.0049) (Fig. 4c ). These data indicate that the modulation of Ca V 2.2 by TSPAN-13 is preserved in the absence of S3 and S4, the LEL and the C-terminus.
Point mutations within TSPAN-13 identify critical amino acid residues for channel modulation. The transmembrane segments S1 and S2 of tetraspanins contain highly conserved amino acid residues which have been shown to mediate tight interactions between both transmembrane domains 12, 13 . The TSPAN-13 transmembrane segments S1 and S2 include several bulky amino acid residues which might be involved in these interactions. Thus, we mutated these candidate amino acids and analysed whether the G max /Q max relationship is affected by expression of TSPAN-13 constructs containing single amino acid mutations in Ca V 2.2-expressing cells.
The mutation of two phenylalanine residues located at positions 55 and 57 in segment S2 to alanine abolished the reduction of G max /Q max , which was observed in the presence of TSPAN-13. In control cells, G max /Q max was 0.18 6 0.01 nS/fC while in the presence of TSPAN-13 (F55A)(F57A) G max /Q max was 0.17 6 0.01 nS/fC (no significant difference) (Fig. 4c) . We further analysed whether a single mutation of F55A or F57A is sufficient to abolish the modulation of the G max /Q max relationship. Indeed, the expression of TSPAN-13 (F55A) or TSPAN-13 (F57A) did not significantly affect G max /Q max compared with controls (0.19 6 0.01 nS/fC to 0.20 6 0.01 nS/fC or 0.19 6 0.01 nS/fC to 0.20 6 0.01 nS/fC, respectively). We further estimated the protein expression level of several TSPAN-13 constructs to ensure that the missing modulatory effect of the TSPAN-13 point mutations is not simply caused by a reduced expression level. Four independent transfection experiments and Western blot analyses were performed using EGFP-tagged TSPAN-13 constructs (Fig. S4 online) . Compared to TSPAN-13 the mutant constructs displayed expression levels that are not significantly different to each other. In fact we even observed a slightly higher expression of the TSPAN-13 (F55A)(F57A) mutant.
In summary, these data indicate that amino acid residues F55 and F57 located within S2 are essential for the modulation of Ca V 2.2 currents by TSPAN-13. To rule out an influence of these mutations on the intracellular localization of TSPAN-13, which might suppress its membrane trafficking and thereby indirectly prevent an interaction between TSPAN-13 and Ca V 2.2, we analysed the intracellular localization of TSPAN-13 mutants F55A, F57A and F55A&F57A. All mutants co-localized with the membrane marker Akt-PH-mCherry and showed a distribution similar to TSPAN-13 making perturbations of intracellular protein localization an unlikely explanation for the observed abrogation of Ca V 2.2 modulation (Fig. 5) . We further mutated a tryptophan residue located within S1 (W33A) to analyse for a possible role in Ca V 2.2 modulation by TSPAN-13. However, expression of TSPAN-13 (W33A) caused a significant reduction of G max /Q max compared with controls (0.20 6 0.01 nS/fC to 0.17 6 0.01 nS/fC, (unpaired two-tail t-test p 5 0.0020)). This reduction was similar to the effect of TSPAN-13 and makes an involvement of W33 in Ca V 2.2 modulation unlikely.
The N-terminus is important for membrane localization of TSPAN-13. Next, we analysed the importance of the N-terminus of TSPAN-13 for the modulation of Ca V 2.2, by constructing a deletion mutant of TSPAN-13 lacking the intracellular N-terminus. By co-transfection of TSPAN-13 DNt , the TSPAN-13 mediated reduction of G max /Q max in Ca V 2.2 expressing cells was abolished. While G max /Q max was 0.20 6 0.01 nS/fC in the presence of TSPAN-13 DNt , corresponding controls showed similar values (0.21 6 0.01 nS/fC; not significant). Importantly, the TSPAN-13 DNt mutant did not co-localize with the membrane marker Akt-PHmCherry (Fig. 5) . TSPAN-13 DNt was rather found in intracellular compartments that potentially resemble the endoplasmic reticulum. We assume that the N-terminus of TSPAN-13 is required for its correct intracellular targeting and that modulation of Ca V 2.2 is abolished because of the absence of TSPAN-13 DNt from the plasma membrane.
Tetraspanin CD81 does not modulate Ca V 2.2. In order to demonstrate that modulation of Ca V 2.2 is not a general property of all members of the tetraspanin family, we investigated the functional role of tetraspanin CD81. In another screening experiment using the split-ubiquitin system we searched for interaction partners of the L-type Ca 21 channel Ca V 1.2 a 1 subunit. Again we used single domains as bait constructs and identified CD81 as a potential interaction partner of the Ca V 1.2 a 1 subunit. A potential modulatory effect of CD81 on Ca V 2.2 was investigated by electrophysiological analysis. The corresponding G max /Q max values were 0.22 6 0.01 (n 5 11) and 0.19 6 0.01 (n 5 9) for control cells and CD81-transfected cells, respectively. These values were not significantly different, indicating that modulation of Ca V 2.2 is specific for TSPAN-13. Discussion In this study we took advantage of the specific qualities of the yeast split-ubiquitin system to further define the interactome of voltagegated Ca 21 channels and have characterized TSPAN-13 as an interaction partner of the Ca V 2.2 Ca 21 channel a 1 subunit. The tetraspanin family of membrane proteins is defined by its consensus structure comprising four transmembrane segments, two characteristic extracellular loops and a conserved CCG motif 14 . The small and large extracellular loops are located between transmembrane segments S1&2 and S3&4, respectively [15] [16] [17] . The large extracellular loop has been described to be essential for the function of different tetraspanins by facilitation of protein-protein interactions [18] [19] [20] . A multitude of interactions between ubiquitously expressed tetraspanins themselves and other membrane proteins typically leads to the formation of the so-called tetraspanin web. Tetraspanin-enriched microdomains are involved in a variety of cellular processes as diverse as cell migration, intracellular trafficking, cell fusion and signalling 16, 21, 22 . However, an interaction of tetraspanins with voltage-gated Ca 21 channels has not been described so far. In order to demonstrate a broad expression of TSPAN-13 in the brain, we performed an RT-PCR analysis. TSPAN-13 encoding mRNA was found in the hippocampus, neocortex and cerebellum. Currently an investigation of TSPAN-13 expression at the protein level was not accomplishable since tetraspanins are extremely homologous to each other, thereby limiting the availability of specific antibodies. Furthermore, many tetraspanins are not sufficiently immunogenic to yield reliable antibodies. Hence, a detailed characterization of tetraspanin-associated proteins and functions is difficult to accomplish and studies are currently restricted to a few tetraspanin members 22 . We found that the modulatory effects of TSPAN-13 are specific for N-type channels and do not occur with L-and T-type Ca 21 channels. This interaction was not identified by a recently published quantitative proteomic approach of Ca V 2 channels 3 . We assume that different methodical approaches favour the identification of certain protein-protein interactions based on their biochemical character. A hydrophobic interaction between transmembrane segments may be lost due to stringent solubilisation and/or co-immunoprecipitation conditions. In fact, it is the strength of our study, to identify interaction partners which could not be detected by other methods. For sure each method has its advantages and disadvantages and probably only their combination gives a more complete map of the Ca V 2.2 interactome.
The interaction between TSPAN-13 and Ca V 2.2 could be located to the membrane-spanning domain IV of the Ca V 2.2 a 1 subunit. The regions of TSPAN-13 required for interaction and modulation of Ca V 2.2 could be narrowed down to a truncated version of TSPAN-13 encompassing the N-terminus and transmembrane segments S1 and S2. Sequence analysis of TSPAN-13 segments S1 and S2 indicates the presence of highly conserved amino acids which have been shown to mediate tight interactions between both transmembrane domains 12, 13 . Mutations of these key residues perturbed intramolecular tetraspanin interactions causing protein destabilization 12 . Importantly, we identified single hydrophobic amino acids located within transmembrane segment S2 to be crucial for the interaction between TSPAN-13 and Ca V 2.2. Because of the hydrophobic nature of domain IV of Ca V 2.2 and S2 of TSPAN-13, we assume that the interaction between both proteins is hydrophobic and takes place inside the membrane environment.
While membrane localization of full-length TSPAN-13 was in agreement with previous studies, where a TSPAN-13-EGFP fusion protein also localized to the plasma membrane in breast cancer cells 23 , TSPAN-13 DNt was rather found in intracellular compartments, presumably the endoplasmic reticulum. Therefore, we assume that the N-terminus of TSPAN-13 is required for its correct intracellular targeting and that the lack of Ca V 2.2 modulation is caused by the absence of TSPAN-13 DNt from the plasma membrane.
The specific interaction between TSPAN-13 and Ca V 2.2, which we observed in the yeast two hybrid system and by co-immunoprecipitation has also specific functional consequences. Our electrophysiological analysis revealed that TSPAN-13 suppressed the amplitude of current through Ca V 2.2 channels in NG108-15 cells. It modulated the voltage-dependent activation and inactivation kinetics of Ca V 2.2 expressed in the CHO cells in a complex way. Reduction of the G max / Q max ratio by an unaltered Q max suggests a lowered opening probability, which is consistent with the observed decrease in the current amplitude. An altered voltage-dependence of t act (V) is consistent with modulation of channel gating 24, 25 . TSPAN-13 facilitated the voltage-dependent channel gating when Ba 21 was used as a charge carrier. Ca 21 -dependent inactivation of the Ca V 2.2 channel remains controversial. While it is generally accepted that calmodulin interacts with Ca V 2.2 channels 26, 27 , its effects on current kinetics were reported by some authors 26, 28 , but questioned by others 29 . In our settings Ba 21 and Ca 21 currents inactivated with similar kinetics. TSPAN-13 did not alter the inactivation kinetics of the Ca 21 current suggesting that it probably does not interfere with the IQ motif.
The Ca 21 current activated faster than the Ba 21 current and was modulated differently by TSPAN-13. The lowered slope factor of the voltage-dependence of t act (V) is consistent with a lowered sensitivity of the channels voltage sensor 24, 25 . Activation kinetics of Ca V 2.2 channels is modulated by G-proteins which constitutively inactivate the channel and this inactivation is relieved by a strong depolarisation called prepulse facilitation 30, 31 . However, prepulse facilitation was not altered by TSPAN-13 ( Fig. S5 online) , therefore we can exclude an interaction between TSPAN-13 and G-proteins.
We assume that the physiologic effect of TSPAN-13 on Ca V 2.2 channels may be much more pronounced as indicated by our characterization based on a recombinant system. In fact in NG108-15 cells we observe a significant suppression of the current through Ca V 2.2 channels, this suppression is not significant in CHO cells expressing Ca V 2.2 and TSPAN-13. In our view these results indicate that the pure recombinant system lacks further important interaction partners which are present in NG108-15 cells. Therefore our recombinant electrophysiological experiments may only partially describe the actual effect of TSPAN-13 on Ca V 2.2 channels.
Another member of the tetraspanins, CD81 was not able to modulate Ca V 2.2 channels. We assume that the modulation by TSPAN-13 represents a novel mechanism for regulation of Ca V 2.2 Ca 21 channel activity, thereby affecting presynaptic transmitter release. The presence of TSPAN-13 in defined synaptic membrane compartments could exclusively influence Ca V 2.2 mediated transmitter release.
Methods
Split-ubiquitin yeast two-hybrid screening. The Split-ubiquitin system (DUALmembrane kit 3) together with a mouse brain cDNA library (pNubGx) were purchased from Dualsystems Biotech (Zurich, Switzerland). Construction of bait vectors and screenings were performed according to the manufacturer's instructions. In particular, domains IV and the C-termini of Ca V 2.2 and Ca V 2.1 were cloned into the pBT3-N vector. Since it turned out that Ca V 2.1 Ca 21 channel constructs did not express in yeast, we used yeast codon-optimized cDNA-fragments of Ca V 2.1. Each screening experiment was performed with about ,1-5 3 10 6 transformants. Library plasmids were isolated from HIS3-and ADE2-positive yeast cells and identified by nucleotide sequencing. To confirm protein-protein-interaction we performed additional assays using PCR-generated full length cDNAs (pPR3N-vector) of the candidate proteins. To analyse the interaction of the individual TSPAN-13-constructs in more detail, we performed a b-galactosidase filter-lift assay according to the manufacturers instructions.
Pellet-b-galactosidase assay. The pellet-b-galactosidase assay allows for a quantitative estimation of the interaction strength between two proteins expressed in the yeast split-ubiquitin system. This assay was developed by Möckli and Auerbach and is described in 7 . Briefly, yeast colonies were grown to an OD 546 of 0.8 to 1.0 and then harvested by centrifugation. Yeast cells were broken by repeated freeze-thaw cycles and resuspended in water. The pellet-b-galactosidase assay was performed in 96-well plates by an overlay of the cells with X-Gal-staining solution. Development of blue color was observed using a flat-bed scanner and quantified by the program Multi Gauge V3.0 (Fujifilm, Düsseldorf, Germany).
RT-PCR analysis. Whole brain and hippocampus, neocortex and cerebellum were prepared from cervical dislocated adult male mice. Total RNA was isolated using the RNeasy Midi and Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. cDNA synthesis was performed by the Transcriptor High Fidelity cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). Oligonucleotide primers for PCR of TSPAN-13 cDNA were selected from different exons to exclude amplification of genomic DNA. The following primers were used: 59-CCACGCGCCACGATGGTGTGCG-39 and 59-CAGCAGCTGACCCTGCTGC TCCCGA-39. PCR fragments were verified by sequence analysis.
Plasmids and co-immunoprecipitation (coIP). For cell-imaging and patch-clamp experiments full-length mouse TSPAN-13 and mutants were PCR-generated and cloned into pEGFP-N1 (Clontech, Saint-Germain-en-Laye, France). CoIPs were performed using N-terminal Myc-tagged-TSPAN-13 pcDNA3-vectors (Invitrogen Darmstadt, Germany). CHO cells and CHO cells stably expressing Ca V 2.2 were co-transfected with vectors encoding Myc-TSPAN-13. For each coIP-experiment cells of five 10 cm dishes were rinsed with ice-cold PBS pH 7.4 (containing proteinaseinhibitor complete 1550 Roche (Roche, Mannheim, Germany)), pooled and thoroughly homogenized. After centrifugation (5 min at 800 3 g at 4uC) supernatants were separated and membrane-enriched protein fractions were isolated by an additional centrifugation-step (16000 3 g for 2 h at 4uC). Pelleted membranes were resuspended in CL142-buffer (Logopharm, Freiburg, Germany) and final protein concentration was adjusted to 1.25 mg/ml. Solubilisation was carried out at 4uC for 16 h under continuous movement, afterwards insoluble material was removed by centrifugation (110 min at 16000 3 g at 4uC). Aliquots of solubilized protein (supernatants) and pellets were resolved in SDS-loading buffer and checked for solubilisation efficiency.
Equal amounts of solubilized proteins (,400-600 ml, c 5 1.25 mg/ml) were added to 50 ml DynaBeadsH Protein G (Invitrogen, Darmstadt, Germany) and 10 mg anti-Myc antibody (Cell-signalling, Frankfurt, Germany) or 10 mg mouse-IgGcontrol (Merck, Darmstadt, Germany). After immunoprecipitation (2.5 h at 4uC), beads were washed and proteins were eluted with SDS-buffer (10 min at 45uC) following manufacturer's instructions.
Western blot analysis. Solubilized proteins and eluates obtained from coIP were separated on 7% and 12% SDS-polyacrylamide gels, respectively. The gels were blotted using a ''wet-blot-chamber'' (Bio-Rad Laboratories, München, Germany) onto nitrocellulose membranes (Carl-Roth, Karlsruhe, Germany). After blocking and washing, membranes were incubated with the primary antibodies anti-Myc-Tag (Cell-signalling, Frankfurt, Germany) or anti-GFP antibody (Abcam Cambridge, United Kingdom). After washing, the secondary antibodies were applied and proteins were detected using an imaging system (LAS-3000 mini, Fujifilm-Europe, www.nature.com/scientificreports SCIENTIFIC REPORTS | 3 : 1777 | DOI: 10.1038/srep01777
Düsseldorf, Germany) according to the manufacturer's instructions. Secondary antibodies were obtained from mouse IgG-POX from Biomol (Hamburg, Germany). Streptavidin-HRP (Cell Signaling, Frankfurt, Germany) was used to detect biotinylated anti-GFP-antibody.
Cell lines and cultivation. NG108-15 cells were grown in DMEM containing 10% fetal calf serum (FCS), 100 U/ml penicillin-streptomycin and 1 mM sodium pyruvate (PAA Laboratories, Cölbe, Germany) in an atmosphere of 5% CO 2, and 95% air at 37uC. Differentiation of cells was induced by addition of 1 mM cAMP to growth medium containing 1% FCS for 11 days. Measurement of Ca V 3.1 and Ca V 1.2 currents was performed in HEK 293 cells stably transfected with Ca V 3.1 containing plasmids 32 or Ca V 1.2 containing plasmids 33 , respectively. Measurement of Ca V 2.1 currents was performed in HEK 293 cells transiently transfected with Ca V 2.1-EGFP-N1 vector and vectors encoding a 2 d-and b3a-subunits 34 . Cells were grown in DMEM containing 10% FCS, 100 U/ml penicillin-streptomycin and 0.02 mg/ml G418 (Biochrom, Berlin, Germany). A CHO cell line stably transfected with rat a1-Ca V 2. Patch pipettes were made from borosilicate glass (Sutter Instrument, Novato, USA). When filled with the intracellular solution, input resistance was between 1.8 and 4.0 MV. The capacitance of individual cells ranged from 5 to 80 pF, depending on the cell line analysed. Capacity transient and series resistance were compensated up to 70% by built-in procedures of the HEKA-10 amplifier. Linear leak current and remaining capacity transients were subtracted using the P/4 procedure. Data were recorded with HEKA Patchmaster 2.43 and analysed offline using HEKA Fitmaster 2.60 and Origin 8.5 software. The holding potential in all experiments was 280 mV, except for measurement of T-type calcium currents where it was 2100 mV. The maximal conductance (G max ) of calcium channels was estimated by fitting currentvoltage curves by combined Boltzmann-Ohm equation.
Measurement and analysis of gating currents. Gating currents were measured at the reversal potential estimated individually for each cell. At such conditions gating currents are not obscured by inward Ca 21 currents and there is no need to use Ca 21 channel blockers 35 . The value of the reversal potential for all cells investigated ranged from 175 to 191 mV. The Q-V relationship for the Ca V 2.2 channel saturates above 110 mV 35 , therefore we can consider the estimated value of Q to be the maximal value for each cell. Five identical traces were recorded and averaged for each cell. Total on-charge was evaluated by integrating the area below gating current trace at the beginning of each depolarizing pulse.
In order to minimize variations potentially caused by individual transfections, we only compared G max /Q max values from the same day from cells transfected either with a control-EGFP plasmid or with specific TSPAN-13 constructs. Results obtained from these pools were then compared for the TSPAN-13 effect. Control groups from all data sets did not differ significantly (ANOVA with Tukey's post-test).
Data analysis and statistics. Data are presented as mean 6 SEM. Statistical significance of differences was determined by two-tail unpaired Student's t test or an ANOVA followed by Tukey's post-test or by a nonparametric Mann-Whitney test as appropriate and considered significant when p , 0.05.
Drugs and reagents. All drugs and chemicals were obtained from Sigma-Aldrich, Taufkirchen, Germany except when stated otherwise.
